Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 28, 2018; 24(12): 1312-1320
Published online Mar 28, 2018. doi: 10.3748/wjg.v24.i12.1312
Published online Mar 28, 2018. doi: 10.3748/wjg.v24.i12.1312
Stage | n | Median | 95%CI |
S0 patients and healthy subjects | 34 | 10.05 | 9.28-11.27 |
S1-S2 patients | 93 | 11.53 | 10.38-13.92 |
S3-S4 patients | 67 | 19.84 | 17.34-20.63 |
AUC (95%CI) | |||
S0 vs S1-S4 | S3-S4 vs S0-S2 | S4 vs S0-S3 | |
IL-34 | 0.753 (0.659-0.848) | 0.809 (0.743-0.875) | 0.815 (0.747-0.883) |
APRI | 0.714 (0.580-0.847) | 0.783 (0.715-0.850) | 0.797 (0.710-0.884) |
FIB-4 | 0.577 (0.427-0.727) | 0.651 (0.564-0.738) | 0.651 (0.529-0.773) |
Forns | 0.529 (0.405-0.653) | 0.762 (0.685-0.839) | 0.788 (0.689-0.886) |
FCI | 0.580 (0.422-0.738) | 0.793 (0.723-0.863) | 0.822 (0.739-0.906) |
Liver stiffness | 0.684 (0.565-0.803) | 0.844 (0.784-0.903) | 0.815 (0.728-0.902) |
- Citation: Wang YQ, Cao WJ, Gao YF, Ye J, Zou GZ. Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol 2018; 24(12): 1312-1320
- URL: https://www.wjgnet.com/1007-9327/full/v24/i12/1312.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i12.1312